NPJ digital medicine · 2026
Transparent chest radiograph foundation model enables explainable human disease profiling.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Chin, Chen Kai-Chieh, Huang Jun-Wei, Fang Wen-Hui, Chang Wei-Chou, Ko Kai-Hsiung, Hsu Yi-Chih, Lin Chin-Sheng, Lin Shih-Hua, Tsai Dung-Jang
Аннотация
Chest radiography (CXR) is widely accessible, and its ability to capture subtle manifestations of systemic disease remains underexplored. We developed a contrastively pretrained multimodal CXR foundation model using large-scale image-report pairs and evaluated its capacity to predict diverse human diseases. Using 1074 phecodes derived from electronic health records, we trained linear probes on frozen image embeddings and validated performance across three independent cohorts (n = 90,911; n = 79,786; n = 60,282). The model significantly predicted 554 prevalent and 457 incident phenotypes, with 60 prevalent and 42 incident phenotypes demonstrating consistently high discrimination across all datasets. To enhance interpretability, both diseases and 57 radiologist-curated CXR features were embedded into a shared representation space. This co-embedding analysis identified 28 phenotype clusters driven by recognizable imaging patterns, including cardiomegaly, atherosclerosis, and ground-glass opacities, and enabled reconstruction of most predictions with strong explanatory performance (R² ≥ 0.85). Importantly, the embeddings captured imaging signatures associated with near-term cardiovascular events and critical illness. These findings demonstrate that CXR foundation model embeddings encode rich, clinically relevant information beyond conventional interpretation, providing a scalable and interpretable framework for comprehensive disease profiling and a foundation for future prospective validation.